LSD1-Mediated Epigenetic Reprogramming Drives CENPE Expression and Prostate Cancer Progression
Androgen receptor (AR) signaling is a key driver of prostate cancer, and androgen-deprivation therapy (ADT) is a standard treatment for patients with advanced and metastatic disease. However, patients receiving ADT eventually develop incurable castration-resistant prostate cancer (CRPC). Here, we re...
Saved in:
Published in | Cancer research (Chicago, Ill.) Vol. 77; no. 20; pp. 5479 - 5490 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Association for Cancer Research, Inc
15.10.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!